Given that atherosclerosis follows a chronic course characterized by a “vicious cycle” (Zhang et al., 2023), each vicious cycle entails an inflammatory response period, and “long-term” implies pre-administration of β-AR blockers before each such period to reduce polarization or quantity of M2-like phenotype macrophages within atherosclerotic plaques. Here, ADRB2 is linked to atherosclerosis.